Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
Retrospective Comparative Study of Oral Versus Subcutaneous Semaglutide in Patients with Type 2 Diabetes Mellitus
International journal of molecular sciences, 2026;27(11)
Recombinant Human Thymosin β4 Attenuates Endotoxemia-Induced ALI and EAE by Suppressing Inflammatory and Oxidative Responses
Biomolecules, 2026;16(6)
Association of Tirzepatide versus Glucagon-Like Peptide-1 Receptor Agonists with Incident Glaucoma in Patients with Type 2 Diabetes: A Retrospective Cohort Study
Ophthalmology science, 2026;6(7):101245
Glucagon-like peptide-1 receptor agonist, semaglutide, attenuates intravenous self-administration of fentanyl in female rats
bioRxiv : the preprint server for biology, 2026
Tirzepatide and Cardiometabolic Effects in Obese Non-diabetic Adults: A Systematic Review, Meta-Analysis, and Narrative Synthesis of Cardiovascular Outcomes
Cureus, 2026;18(5):e109350
BPC-157 as an Investigational Peptide Therapeutic: Biopharmaceutical Challenges, Formulation Strategies, and Translational Development Barriers
Pharmaceutics, 2026;18(5)
A rationally designed 18-amino acid peptide with potential as GLP-1 receptor agonist
Frontiers in pharmacology, 2026;17:1789257
Injectable Peptides in Sports Medicine: A Structured Narrative Review of Evidence, Safety, and Antidoping Implications
JBJS reviews, 2026;14(5)
Clinical impact of tirzepatide on patients with chronic obstructive pulmonary disease
Frontiers in pharmacology, 2026;17:1838392
Psychosocial Outcomes in Telemedicine and Long-Acting Incretin-Specific Behavioral Intervention
Obesity science & practice, 2026;12(3):e70149
Efficacy and safety of novel formulation of semaglutide injection: A multicentre, randomized, comparative, active controlled, phase 3 study in comparison with reference biologic in Indian patients with type 2 diabetes mellitus
Metabolism open, 2026;30:100476
Corrigendum to “Efficacy and safety of semaglutide injection in comparison with reference semaglutide for chronic weight management in Indian adults with obesity: A phase III randomized non-inferiority trial” [Metabol Open 30 (2026) 100460]
Metabolism open, 2026;30:100477
A Case of an Invisible Pancreatic Neuroendocrine Tumor Decoded by Endoscopic Ultrasound
Cureus, 2026;18(5):e109296
Comparative effectiveness of tirzepatide versus GLP-1 receptor agonists on the risk of venous thromboembolism in patients with obesity: a real-world cohort study
Frontiers in medicine, 2026;13:1820366
Swiss obesity clinical practice guidance
Swiss medical weekly, 2026;156:5415
Structure-Property-Performance Engineering of Hydrogel Depots for Long-Acting Peptide Delivery
bioRxiv : the preprint server for biology, 2026
Semaglutide and Follow-On Peptide Therapeutics: Balancing Innovation, Regulation, and Clinical Outcomes
Cureus, 2026;18(5):e108999
GLP-1 Receptor Agonists in Hidradenitis Suppurativa: Time to Treat the Whole Patient
Skin appendage disorders, 2026
Efficacy and Safety of Oral Semaglutide in the Management of Diabetes and Obesity: A Comprehensive Meta-analysis of Real-world Evidence
TouchREVIEWS in endocrinology, 2026;22(1):16-28
Early changes in body composition with tirzepatide in adults with obesity: a real-world BIA study
Nutrition (Burbank, Los Angeles County, Calif.), 2026;150:113286